Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme
- 13 July 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 57 (32) , 4903-4914
Abstract
Insulin-degrading enzyme (IDE) is a 110 kDa chambered zinc metalloendopeptidase that degrades insulin, amyloid beta, and other intermediate-sized aggregation prone peptides that adopt β-structures. Structural studies of IDE in complex with multiple physiological substrates have suggested a role for hydrophobic and aromatic residues of the IDE active site in substrate binding and catalysis. Here, we examine functional requirements for conserved hydrophobic and aromatic IDE active site residues that are positioned within 4.5 Angstroms of IDE bound insulin B chain and amyloid beta peptides in the reported crystal structures for the respective enzyme-substrate complexes. Charge, size, hydrophobicity, aromaticity, and other functional group requirements for substrate binding IDE active site residues were examined through mutational analysis of the recombinant human enzyme and enzyme kinetic studies conducted using native and fluorogenic derivatives of human insulin and amyloid beta peptides. A functional requirement for IDE active site residues F115, A140, F141, Y150, W199, F202, F820, and Y831 was established, and specific contributions of residue charge, size and hydrophobicity in substrate binding, specificity, and proteolysis were demonstrated. IDE mutant alleles that exhibited enhanced or diminished proteolytic activity towards insulin or amyloid beta peptides and derivative substrates were identified.Keywords
Funding Information
- Division of Chemistry (CHE-1624774)
- Department of Chemistry, Sacred Heart University
- College of Arts and Sciences, Sacred Heart University
This publication has 43 references indexed in Scilit:
- The completion of the Mammalian Gene Collection (MGC)Genome Research, 2009
- Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading EnzymeBiochemistry, 2008
- MEROPS: the peptidase databaseNucleic Acids Research, 2007
- Structure of Substrate-free Human Insulin-degrading Enzyme (IDE) and Biophysical Analysis of ATP-induced Conformational Switch of IDEJournal of Biological Chemistry, 2007
- Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanismNature, 2006
- Enzyme target to latch on toNature, 2006
- Differential Degradation of Amyloid β Genetic Variants Associated with Hereditary Dementia or Stroke by Insulin-degrading EnzymeJournal of Biological Chemistry, 2003
- Analysis of the Subsite Specificity of Rat Insulysin Using Fluorogenic Peptide SubstratesJournal of Biological Chemistry, 2001
- Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzymeFEBS Letters, 1994
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967